Pieris, Sanofi deal

The companies will expand a 2010 deal under which Pieris is using its Anticalin technology to discover and develop

Read the full 190 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE